VIRI logo

Virios Therapeutics (VIRI) Net Income

Annual Net Income

-$5.30 M
+$6.95 M+56.76%

31 December 2023

VIRI Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Net Income

-$2.28 M
-$1.23 M-117.25%

30 September 2024

VIRI Quarterly Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Net Income

-$5.72 M
-$1.05 M-22.34%

30 September 2024

VIRI TTM Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

VIRI Net Income Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+56.8%-84.7%+8.2%
3 y3 years+48.8%+44.5%+68.1%
5 y5 years-150.6%-180.9%-314.9%

VIRI Net Income High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+66.8%-117.3%+49.5%-22.3%+68.1%
5 y5 years-150.6%+66.8%-388.8%+64.9%-314.9%+68.1%
alltimeall time-150.6%+66.8%-388.8%+64.9%-908.1%+68.1%

Virios Therapeutics Net Income History

DateAnnualQuarterlyTTM
Sept 2024
-
-$2.28 M(+117.2%)
-$5.72 M(+22.3%)
June 2024
-
-$1.05 M(-18.7%)
-$4.68 M(-7.7%)
Mar 2024
-
-$1.29 M(+17.1%)
-$5.07 M(-4.3%)
Dec 2023
-$5.30 M(-56.8%)
-$1.10 M(-10.7%)
-$5.30 M(-15.1%)
Sept 2023
-
-$1.24 M(-14.3%)
-$6.24 M(-17.7%)
June 2023
-
-$1.44 M(-5.0%)
-$7.58 M(-22.7%)
Mar 2023
-
-$1.52 M(-25.8%)
-$9.80 M(-19.9%)
Dec 2022
-$12.25 M(-23.3%)
-$2.04 M(-20.6%)
-$12.25 M(-16.8%)
Sept 2022
-
-$2.58 M(-29.8%)
-$14.71 M(-9.4%)
June 2022
-
-$3.67 M(-7.4%)
-$16.25 M(-3.7%)
Mar 2022
-
-$3.96 M(-12.2%)
-$16.86 M(+5.7%)
DateAnnualQuarterlyTTM
Dec 2021
-$15.96 M(+54.3%)
-$4.51 M(+9.8%)
-$15.96 M(-11.1%)
Sept 2021
-
-$4.11 M(-4.0%)
-$17.95 M(+8.4%)
June 2021
-
-$4.28 M(+40.2%)
-$16.56 M(+28.0%)
Mar 2021
-
-$3.06 M(-53.0%)
-$12.94 M(+25.0%)
Dec 2020
-$10.35 M(+318.3%)
-$6.50 M(+138.7%)
-$10.35 M(+130.8%)
Sept 2020
-
-$2.72 M(+316.1%)
-$4.48 M(+74.4%)
June 2020
-
-$654.60 K(+40.3%)
-$2.57 M(+3.5%)
Mar 2020
-
-$466.60 K(-26.9%)
-$2.48 M(+23.1%)
Dec 2019
-$2.47 M(+17.0%)
-$638.60 K(-21.3%)
-$2.02 M(+46.3%)
Sept 2019
-
-$811.80 K(+42.9%)
-$1.38 M(+142.9%)
June 2019
-
-$567.90 K
-$567.90 K
Dec 2018
-$2.11 M
-
-

FAQ

  • What is Virios Therapeutics annual net profit?
  • What is the all time high annual net income for Virios Therapeutics?
  • What is Virios Therapeutics annual net income year-on-year change?
  • What is Virios Therapeutics quarterly net profit?
  • What is the all time high quarterly net income for Virios Therapeutics?
  • What is Virios Therapeutics quarterly net income year-on-year change?
  • What is Virios Therapeutics TTM net profit?
  • What is the all time high TTM net income for Virios Therapeutics?
  • What is Virios Therapeutics TTM net income year-on-year change?

What is Virios Therapeutics annual net profit?

The current annual net income of VIRI is -$5.30 M

What is the all time high annual net income for Virios Therapeutics?

Virios Therapeutics all-time high annual net profit is -$2.11 M

What is Virios Therapeutics annual net income year-on-year change?

Over the past year, VIRI annual net profit has changed by +$6.95 M (+56.76%)

What is Virios Therapeutics quarterly net profit?

The current quarterly net income of VIRI is -$2.28 M

What is the all time high quarterly net income for Virios Therapeutics?

Virios Therapeutics all-time high quarterly net profit is -$466.60 K

What is Virios Therapeutics quarterly net income year-on-year change?

Over the past year, VIRI quarterly net profit has changed by -$1.05 M (-84.66%)

What is Virios Therapeutics TTM net profit?

The current TTM net income of VIRI is -$5.72 M

What is the all time high TTM net income for Virios Therapeutics?

Virios Therapeutics all-time high TTM net profit is -$567.90 K

What is Virios Therapeutics TTM net income year-on-year change?

Over the past year, VIRI TTM net profit has changed by +$512.52 K (+8.22%)